GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Additional Paid-In Capital

Rapid Dose Therapeutics (XCNQ:DOSE) Additional Paid-In Capital : C$0.00 Mil(As of Aug. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics Additional Paid-In Capital?


Rapid Dose Therapeutics's quarterly additional paid-in capital declined from Feb. 2024 (C$5.24 Mil) to May. 2024 (C$0.00 Mil) but then stayed the same from May. 2024 (C$0.00 Mil) to Aug. 2024 (C$0.00 Mil).

Rapid Dose Therapeutics's annual additional paid-in capital increased from Feb. 2022 (C$4.15 Mil) to Feb. 2023 (C$4.85 Mil) and increased from Feb. 2023 (C$4.85 Mil) to Feb. 2024 (C$5.24 Mil).

Rapid Dose Therapeutics Additional Paid-In Capital Historical Data

The historical data trend for Rapid Dose Therapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Additional Paid-In Capital Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.64 4.15 4.85 5.24

Rapid Dose Therapeutics Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.85 4.85 5.24 - -

Rapid Dose Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Rapid Dose Therapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Additional Paid-In Capital
Comparable Companies
XCNQ:MDMA XCNQ:TELI TSX:APS XCNQ:PHRM TSXV:TTI TSXV:GSD XCNQ:BIOV TSXV:SBM TSXV:CYTO XCNQ:DTC VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
RDTCF:USA
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Website
https://www.rapid-dose.com
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
Executives
Mark Upsdell Director
Brian Howlett Director

Rapid Dose Therapeutics Headlines

No Headlines